Second Opinion Oncology

Alectinib: A Breakthrough Therapy for ALK-Driven Cancers Alectinib, sold under the brand name Alecensa, is a powerful targeted therapy...

In our last article, "Revolutionizing Cancer Treatment: The Promise of Stereotactic Body Radiation Therapy (SBRT)," , we explored how...

Introduction In our last article, "Revolutionizing Cancer Treatment: The Promise of Stereotactic Body Radiation Therapy (SBRT)," , we...

Introduction In our last article, "Revolutionizing Cancer Treatment: The Promise of Stereotactic Body Radiation Therapy (SBRT)," , we...